Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Enterobacteria producing extended spectrum beta-lactamases]

J C Lucet1, B Régnier

  • 1Unité d'Hygiène et de Lutte contre l'Infection Nosocomiale, Hôpital Bichat-Claude Bernard, Paris, France.

Pathologie-Biologie
|October 14, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bathroom contamination by antibiotic-resistant Enterobacterales (ESBLPE and CPE): an experimental study.

The Journal of hospital infection·2020
Same author

Awareness among French healthcare workers of the transmission of multidrug resistant organisms: a large cross-sectional survey.

Antimicrobial resistance and infection control·2019
Same author

Less contact isolation is more in the ICU: not sure.

Intensive care medicine·2019
Same author

Prescribers' experience and opinions on antimicrobial stewardship programmes in hospitals: a French nationwide survey.

The Journal of antimicrobial chemotherapy·2019
Same author

Clinical management of respiratory syndrome in patients hospitalized for suspected Middle East respiratory syndrome coronavirus infection in the Paris area from 2013 to 2016.

BMC infectious diseases·2018
Same author

High-dose daptomycin in patients with infective endocarditis or sternal wound infections.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2018
Same journal

Pathologie-biologie·2020
Same journal

Antibacterial and antibiofilm activities of Laurus nobilis L. essential oil against Staphylococcus aureus strains associated with oral infections.

Pathologie-biologie·2015
Same journal

[Not Available].

Pathologie-biologie·2015
Same journal

Oxidative damage and histopathological changes in lung of rat chronically exposed to nicotine alone or associated to ethanol.

Pathologie-biologie·2015
Same journal

Biological diagnosis of diabetes mellitus.

Pathologie-biologie·2015
Same journal

Association of CagPAI integrity with severeness of Helicobacter pylori infection in patients with gastritis.

Pathologie-biologie·2015
See all related articles

Extended-spectrum beta-lactamases (ESBLs) have rapidly increased globally since 1983. Containment strategies involve barrier precautions and judicious antibiotic use to reduce spread.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Context:

  • Extended-spectrum beta-lactamases (ESBLs) emerged in 1983 and have since spread globally.
  • Over 30 types of ESBLs have been identified, with significant prevalence in countries like France.
  • Initial outbreaks occurred in intensive care units, with nursing home patients potentially reintroducing ESBLs into acute care settings.

Purpose:

  • To review the epidemiology and clinical significance of ESBL-producing Enterobacteriaceae.
  • To highlight the transmission routes and risk factors associated with ESBL colonization and infection.
  • To discuss strategies for controlling the spread of ESBL-producing bacteria.

Summary:

  • ESBLs are primarily found in the digestive tract, with transmission occurring via hands.

Related Experiment Videos

  • Approximately 50% of colonized patients develop infections, frequently urinary tract infections.
  • Key risk factors include prolonged exposure to epidemic strains and frequent healthcare worker contact.

    • Impact:

    • Understanding ESBL epidemiology is crucial for effective infection control.
    • Barrier precautions for carriers and prudent antimicrobial stewardship are vital for containment.
    • Minimizing antibiotic selective pressure can help curb the spread of resistant strains.